Publications by authors named "Michael Lauseker"

48Publications

Influence of somatic mutations and pretransplant strategies in patients allografted for myelodysplastic syndrome or secondary acute myeloid leukemia.

Am J Hematol 2020 Oct 5. Epub 2020 Oct 5.

Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine - University, Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.26013DOI Listing
October 2020

Hemispheric differences in the duration of focal onset seizures.

Acta Neurol Scand 2020 Oct 4. Epub 2020 Oct 4.

Epilepsy Center, Department of Neurology, University Hospital, LMU Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ane.13356DOI Listing
October 2020

Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.

J Heart Lung Transplant 2020 Aug 26. Epub 2020 Aug 26.

Department of Internal Medicine V, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL). Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.healun.2020.08.008DOI Listing
August 2020

Who seizes longest? Impact of clinical and demographic factors.

Epilepsia 2020 07 21;61(7):1376-1385. Epub 2020 Jun 21.

Department of Neurology, Epilepsy Center, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/epi.16577DOI Listing
July 2020

Estimating the distribution of heterogeneous treatment effects from treatment responses and from a predictive biomarker in a parallel-group RCT: A structural model approach.

Biom J 2020 05 4;62(3):697-711. Epub 2020 Mar 4.

Faculty of Medicine, Institute for Medical Information Processing, Biometry, and Epidemiology, LMU Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bimj.201800370DOI Listing
May 2020

Infections after kidney transplantation: A comparison of mTOR-Is and CNIs as basic immunosuppressants. A systematic review and meta-analysis.

Transpl Infect Dis 2020 Jun 6;22(3):e13267. Epub 2020 Mar 6.

Department of General-, Visceral- and Transplantation-Surgery, Ludwig-Maximilian's University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tid.13267DOI Listing
June 2020

Differences in treatment and monitoring of chronic myeloid leukemia with regard to age, but not sex: Results from a population-based study.

Eur J Haematol 2019 Oct 28;103(4):362-369. Epub 2019 Aug 28.

Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13293DOI Listing
October 2019

Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia.

Biol Blood Marrow Transplant 2019 08 15;25(8):1550-1559. Epub 2019 Mar 15.

Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.03.011DOI Listing
August 2019

Analysis of cause of death: Competing risks or progressive illness-death model?

Biom J 2019 03 25;61(2):264-274. Epub 2019 Jan 25.

Department of Epidemiology, Medical Statistics and Decision Making, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/bimj.201700238
Publisher Site
http://dx.doi.org/10.1002/bimj.201700238DOI Listing
March 2019

CCL1 is a major regulatory T cell attracting factor in human breast cancer.

BMC Cancer 2018 Dec 20;18(1):1278. Epub 2018 Dec 20.

Center of Integrated Protein Science Munich (CIPS-M), Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-5117-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302432PMC
December 2018

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.

Haematologica 2019 05 4;104(5):955-962. Epub 2018 Dec 4.

Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.206797DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518910PMC
May 2019

Development of novel biological resection criteria for safe and oncologically satisfying resection of hepatocellular carcinoma.

Surg Oncol 2018 Dec 30;27(4):663-673. Epub 2018 Aug 30.

Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany; Transplantationcentre Munich, Hospital of the LMU, Campus Großhadern, Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09607404183015
Publisher Site
http://dx.doi.org/10.1016/j.suronc.2018.08.007DOI Listing
December 2018

The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance.

Endocr Relat Cancer 2018 10 12;25(10):893-908. Epub 2018 Jun 12.

Medizinische Klinik und Poliklinik IVInterdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM), Klinikum der Universität München (KUM), Ludwig-Maximilians-University, Munich, Germany

View Article

Download full-text PDF

Source
https://erc.bioscientifica.com/view/journals/erc/25/10/ERC-1
Publisher Site
http://dx.doi.org/10.1530/ERC-18-0159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439002PMC
October 2018

Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.

Cancer 2017 Dec 26;123(23):4608-4616. Epub 2017 Jul 26.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Dusseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30917DOI Listing
December 2017

Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death.

Cancer 2017 Jul 13;123(13):2467-2471. Epub 2017 Feb 13.

Institute for Medical Information Sciences, Biometry, and Epidemiology (IBE), Ludwig-Maximilians University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30636DOI Listing
July 2017

Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study.

J Cancer Res Clin Oncol 2016 Jul 16;142(7):1441-7. Epub 2016 Apr 16.

Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-016-2155-yDOI Listing
July 2016

Reflections on the true nature of spatial clusters in myelodysplastic syndromes.

Authors:
Michael Lauseker

Leuk Lymphoma 2016 Feb 8;57(2):254-255. Epub 2015 Oct 8.

a Ludwig-Maximilians-Universität München, Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie , München , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1081193DOI Listing
February 2016

In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over time.

Br J Haematol 2015 Sep 11;170(5):687-93. Epub 2015 May 11.

Klinik für Hämatologie Onkologie und Klinische Immunologie, Heinrich-Heine-Universität, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13496DOI Listing
September 2015

Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death.

Ann Hematol 2015 Apr 27;94 Suppl 2:S209-18. Epub 2015 Mar 27.

Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie-IBE, Ludwig-Maximilians-Universität, Marchioninistraße 15, 81377, München, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2316-0DOI Listing
April 2015

A multi-state model approach for prediction in chronic myeloid leukaemia.

Ann Hematol 2015 Jun 3;94(6):919-27. Epub 2014 Dec 3.

Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2246-2DOI Listing
June 2015

Remission status should not be treated as a base-line covariate--reply to Etienne et al.

Haematologica 2014 Sep;99(9):e174-5

Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität, München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.108951DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562554PMC
September 2014

Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase.

J Cancer Res Clin Oncol 2014 Nov 22;140(11):1965-9. Epub 2014 Jun 22.

Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-014-1746-8DOI Listing
November 2014

Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice.

Endocrinology 2014 Jul 24;155(7):2377-90. Epub 2014 Apr 24.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (S.N., A.Gi., Y.T., P.B., J.S., K.P.), National Institutes of Health, Bethesda, Maryland 20892; Department of Endocrinology (S.N., K.Y., M.K.), William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London EC1M 6BQ, United Kingdom; Department of Internal Medicine II (S.N., B.G., G.V.), Campus Grosshadern, University-Hospital of the Ludwig-Maximilians-University of Munich, and Institute of Medical Informatics, Biometry, and Epidemiology (M.L.), University of Munich, Munich 81377, Germany; Department of Molecular Medicine (P.B.), Institute of Virology, Slovak Academy of Sciences, Bratislava 84505, Slovakia; Department of Internal Medicine III (J.S.), Nephrology, Rheumatology, and Endocrinology, Faculty of Medicine and Dentistry, Palacky University, Olomouc 77520, Czech Republic; Leidos Biomedical Research, Inc (M.A.), Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702; First Medical Department (S.F.), University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck 23538, Germany; and Oxford Centre for Diabetes, Endocrinology and Metabolism (A.Gr.), University of Oxford, Oxford OX3 7LE, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2014-1027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060189PMC
July 2014

The impact of health care settings on survival time of patients with chronic myeloid leukemia.

Blood 2014 Apr 12;123(16):2494-6. Epub 2014 Mar 12.

Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität, München, Germany; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-11-539742DOI Listing
April 2014

Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV.

J Clin Oncol 2014 Feb 2;32(5):415-23. Epub 2013 Dec 2.

Rüdiger Hehlmann, Martin C. Müller, Benjamin Hanfstein, Alice Fabarius, Annette Schreiber, Ulrike Proetel, Nadine Pletsch, Susanne Saußele, Universitätsmedizin Mannheim Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim; Jolanta Dengler Universitätsklinikum Heidelberg, Heidelberg; Michael Lauseker, Markus Pfirrmann, Joerg Hasford, Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität; Christoph Nerl, Städtisches Klinikum Munchen Schwabing; Hans-Jochem Kolb, Klinikum rechts der Isar, Technische Universität München; Karsten Spiekermann, Universitätsklinikum, Ludwig-Maximilians Universität München; Claudia Haferlach, Susanne Schnittger, MLL Münchner Leukämielabor, Munich; Hermann Einsele, Universitätsklinikum Würzburg, Würzburg; Christiane Falge, Klinikum Nürnberg Nord, Nuremberg; Lothar Kanz, Universitätsklinikum Tübingen, Tübingen; Andreas Neubauer, Universitätsklinikum Gießen und Marburg, Marburg; Michael Kneba, Universitätsklinikum Schleswig-Holstein, Kiel; Frank Stegelmann, Hermann Heimpel, Universitätsklinikum Ulm, Ulm; Michael Pfreundschuh, Universitätsklinikum des Saarlandes, Homburg/Saar; Cornelius F. Waller, Universitätsklinikum Freiburg, Freiburg; Gerhard Ehninger, Universitätsklinikum Carl Gustav Carus, Dresden; Stefan W. Krause, Universitätsklinikum Erlangen, Erlangen; Dieter K. Hossfeld, Universitätsklinikum Eppendorf, Hamburg; Andreas Hochhaus, Universitätsklinikum Jena, Jena, Germany; Gabriela M. Baerlocher, Inselspital Bern, Bern; Dominik Heim, Universitätsspital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.9020DOI Listing
February 2014

Chromogranin a as serum marker for gastroenteropancreatic neuroendocrine tumors: a single center experience and literature review.

Cancers (Basel) 2012 Feb 15;4(1):141-55. Epub 2012 Feb 15.

Department of Internal Medicine II, Campus Grosshadern, University-Hospital of the Ludwig-Maximilians-University of Munich, Munich 81377, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers4010141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712684PMC
February 2012